SOUTH SAN FRANCISCO, Calif., October 09, 2025--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology ...
Sarah Mae Ives donates generously to the Ataxia-Telangiectasia (A-T) Children's Project in Canada, a nonprofit supporting children with this genetic disease. VICTORIA, British Columbia, June 14, 2023 ...
Sarah Officer, 41, said the approval process is "taking too long" and that her son Jake is "not the kid he used to be" as his incurable condition progresses ...
SOUTH SAN FRANCISCO, Calif., January 28, 2026--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology ...
Researchers have identified covert deletions of the proximal FXN gene that standard testing mistakes for identical repeat ...
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study We identified 421 ...
Friedreich’s ataxia is a progressive neuromuscular disease that causes uncoordinated movement, muscle weakness, balance problems, impaired speech, and frequently, heart abnormalities. Most treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results